Sale!

LRTOMT Gene Deafness Autosomal Recessive Type 63 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LRTOMT Gene Deafness Autosomal Recessive Type 63 Genetic Test is a specialized diagnostic tool designed to identify mutations in the LRTOMT gene, which are linked to a specific form of hereditary hearing loss known as Autosomal Recessive Deafness Type 63. This condition is characterized by the inheritance of two copies of the mutated gene, one from each parent, leading to a high risk of developing hearing impairment from birth or early childhood. The test involves analyzing the patient’s DNA to pinpoint any alterations in the LRTOMT gene that are associated with this type of hearing loss.

Offered by DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test is priced at 4400 AED. DNA Labs UAE employs state-of-the-art technology and methodologies to ensure accurate and reliable results, providing essential information for the diagnosis and management of genetic hearing loss. By identifying the genetic basis of deafness in affected individuals, this test plays a crucial role in guiding treatment decisions, including the consideration of hearing aids, cochlear implants, and other interventions aimed at improving quality of life for those with Autosomal Recessive Deafness Type 63.

Description

LRTOMT Gene Deafness Autosomal Recessive Type 63 Genetic Test

Test Name: LRTOMT Gene Deafness Autosomal Recessive Type 63 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A11

Test Details: LRTOMT stands for “Lateral rotatory type of nystagmus with deafness” and is a genetic disorder characterized by hearing loss and abnormal eye movements. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. NGS stands for “Next-Generation Sequencing,” which is a high-throughput DNA sequencing technology used to analyze multiple genes simultaneously. In the context of genetic testing, NGS can be used to identify mutations or variations in genes associated with specific disorders, such as LRTOMT. Therefore, the “Gene Deafness, autosomal recessive type 63 NGS Genetic Test” refers to a genetic test that uses Next-Generation Sequencing to analyze the LRTOMT gene and identify any mutations or variations that may be responsible for autosomal recessive deafness type 63.

Test Name	LRTOMT Gene Deafness autosomal recessive type 63 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A11
Test Details	LRTOMT stands for “Lateral rotatory type of nystagmus with deafness” and is a genetic disorder characterized by hearing loss and abnormal eye movements. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. NGS stands for “Next-Generation Sequencing,” which is a high-throughput DNA sequencing technology used to analyze multiple genes simultaneously. In the context of genetic testing, NGS can be used to identify mutations or variations in genes associated with specific disorders, such as LRTOMT. Therefore, the “Gene Deafness, autosomal recessive type 63 NGS Genetic Test” refers to a genetic test that uses Next-Generation Sequencing to analyze the LRTOMT gene and identify any mutations or variations that may be responsible for autosomal recessive deafness type 63.